Shijiazhuang Hongray Group, a China-based manufacturer of medical and protective equipment, is seeking a suitable location in Cambodia to establish a new medical manufacturing plant. The proposed investment aligns with the company’s strategy to expand its production footprint in Southeast Asia and strengthen its global supply capabilities for medical-grade products.
The planned facility is expected to focus on the production of medical gloves and related personal protective equipment used in healthcare, industrial, and laboratory settings. Cambodia has emerged as an attractive destination for such investments due to its growing industrial ecosystem, competitive operating environment, and access to regional and international markets. The country’s special economic zones, established infrastructure, and improving logistics network are key factors supporting manufacturing expansion.
As part of this initiative, Shijiazhuang Hongray Group is evaluating locations that can support large-scale, automated production lines while meeting international quality and compliance standards. The company brings decades of manufacturing experience and supplies its products to multiple global markets, serving hospitals, distributors, and healthcare providers across Asia, Europe, and other regions. Its product range includes disposable medical gloves and protective equipment designed to meet global safety requirements.
The proposed manufacturing plant is expected to contribute to Cambodia’s industrial development by supporting local employment and strengthening the country’s position in the regional medical manufacturing supply chain. Investments in modern machinery, process automation, and quality control systems are anticipated to form a core part of the project, ensuring consistent production capacity and product reliability.
Industry observers note that rising global demand for medical gloves and protective equipment continues to drive manufacturers to diversify production locations. Establishing facilities in Southeast Asia allows companies to improve supply chain resilience, reduce dependency on single-market production, and respond more efficiently to international demand fluctuations.
If finalized, the Cambodia facility would mark a significant step in Shijiazhuang Hongray Group’s international expansion plans. The project reflects broader trends in the medical manufacturing sector, where companies are increasingly seeking strategic locations to support long-term growth, operational efficiency, and global market access. The development is expected to further enhance Cambodia’s profile as an emerging hub for medical and healthcare manufacturing in the region.
Also Read: Cambodia International Trade 2025: $65.25B with 18% Growth
